Deema Gashgarey, Mohammed Alsuhaibani, Raghad Alhuthil, Hattan Alhabshan, Azzam Alabdulqader, Rakan Badran, Abdulaziz Balhmar, Haifa Aldawood, Esam A AlBanyan, Salem AlGhamdi, Suliman AlJumaah, Ohoud AlYabes, Sami Al-Hajjar
BACKGROUND: The burden of respiratory syncytial virus (RSV) in high-risk pediatric patients remains unclear. Therefore, this study aims to characterize pediatric RSV cases from January 2019 to December 2022 and assess the impact of the COVID-19 pandemic on RSV burden and RSV-related outcomes. In addition, examining factors influencing RSV-related hospitalization. METHODS: This is a retrospective study that included pediatric patients (aged 14 and below) who presented at King Faisal Specialist Hospital and Research Centre (KFSHRC) in Riyadh, Saudi Arabia with RSV infection identified using real-time reverse-transcriptase polymerase chain reaction assays...
April 4, 2024: Journal of Epidemiology and Global Health